Resources » Desmopressin (DDAVP)
LINKS
DETAILS

Year: 2016

Language: English

This resource is also available in: Arabic French Russian Spanish Simplified Chinese

Author(s): World Federation of Hemophilia

Format: Document

Desmopressin (DDAVP)

ADDITIONAL INFORMATION

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish


Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than plasma products or recombinant clotting factor concentrates, carries no risk of transmission of viral infections, and is on the World Health Organization’s (WHO) Model List of Essential Medicines (EML).

RELATED RESOURCES

Documents and PDFs

Benefits of a National Patient Registry – Japanese

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese 患者登録は、健康上の傾向のモニタリング、資源の割り当て、治療用製剤供給の調整および追跡、全国規模での購入プロセスの改善に極めて重要です。

Read More >
Copy resource link